Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 27.446K / 1.199M |
Day Range | - - - |
52 Wk Range | 316.430 - 448.400 |
Market Cap | $101.949B |
P/E Ratio | 28.632 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 1.54% |
Days to Cover | 4.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.
Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Guggenheim on Thursday, April 18, 2024. The analyst firm set a price target for 450.00 expecting VRTX to rise to within 12 months (a possible 14.08% upside). 84 analyst firms have reported ratings in the last year.
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $394.45 last updated Today at April 26, 2024 at 9:36 AM EDT.
There are no upcoming dividends for Vertex Pharmaceuticals.
Vertex Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Vertex Pharmaceuticals.
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.